Harnessing the type I CRISPR‐Cas systems for genome editing in prokaryotes

Abstract

Genetic analysis is crucial to the understanding, exploitation, and control of microorganisms. The advent of CRISPR‐Cas‐based genome‐editing techniques, particularly those mediated by the single‐effector (Cas9 and Cas12a) class 2 CRISPR‐Cas systems, has revolutionized the genetics in model eukaryotic organisms. However, their applications in prokaryotes are rather limited, largely owing to the exceptional diversity of DNA homeostasis in microorganisms and severe cytotoxicity of overexpressing these nuclease proteins in certain genotypes. Remarkably, CRISPR‐Cas systems belonging to different classes and types are continuously identified in prokaryotic genomes and serve as a deep reservoir for expansion of the CRISPR‐based genetic toolkits. ~90% of the CRISPR‐Cas systems identified so far belong to the class 1 system which hinges on multi‐protein effector complexes for DNA interference. Harnessing these widespread native CRISPR‐Cas systems for ‘built‐in’ genome editing represents an emerging and powerful genetic tool in prokaryotes, especially in the genetically recalcitrant non‐model species and strains. In this progress review, we introduce the general workflow of this emerging editing platform and summarize its establishment in a growing number of prokaryotes by harnessing the most widespread, diverse type I CRISPR‐Cas systems present in their genomes. We also discuss the various factors affecting the success and efficiency of this editing platform and the corresponding solutions.